590 kr
Tax included.
Shipping calculated at checkout.
For Laboratory Research Use Only
Not intended for human or veterinary use.
Your bag is empty.
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analogue supplied for laboratory research use only.
Published scientific literature has investigated Tesamorelin in relation to GHRH receptor biology, growth hormone physiology, endocrine signaling and metabolic research models.
Product Name: Tesamorelin
Product Type: Synthetic GHRH Analogue
Amount: 10 mg
Form: Lyophilized Powder
Purity: ≥99%
Storage: 2–8°C
Batch Testing: Batch-Specific COA Available
Intended Use: Research Use Only
Each batch is linked to a batch-specific Certificate of Analysis (COA).
Available documentation may include purity testing, identity verification, and batch-related analytical data.
Falutz J, Allas S, Mamputu JC, Potvin D, Kotler D, Somero M, et al.
Metabolic effects of a growth hormone-releasing factor in patients with HIV.
New England Journal of Medicine. 2007;357(23):2359–2370.
PMID: 18057338 
DOI: 10.1056/NEJMoa072375
Falutz J, Mamputu JC, Potvin D, Moyle G, Soulban G, Loughrey H, et al.
Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data.
Journal of Clinical Endocrinology & Metabolism. 2010;95(9):4291–4304.
PMID: 20554713
DOI: 10.1210/jc.2010-0490
Stanley TL, Feldpausch MN, Oh J, Branch KL, Lee H, Torriani M, et al.
Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial.
JAMA. 2014;312(4):380–389.
PMID: 25038357
DOI: 10.1001/jama.2014.8334
Dhillon S.
Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy.
Drugs. 2011;71(8):1071–1091.
PMID: 21668043
DOI: 10.2165/11202240-000000000-00000
Product Name: Tesamorelin
Product Type: Synthetic GHRH Analogue
Amount: 10 mg
Form: Lyophilized Powder
Purity: ≥99%
Storage: 2–8°C
Batch Testing: Batch-Specific COA Available
Intended Use: Research Use Only
This product is supplied strictly for laboratory research purposes.
It is not intended for human use, veterinary use, diagnostic applications, or therapeutic and clinical applications.
True Peptides does not provide dosing guidance, administration instructions, or usage recommendations.
Product Name: 10-Amino-1MQ 50 mg
LOT Number: 240710A
Expiration Date: July 18, 2028
Storage Conditions: 2–8 °C, unless otherwise specified
Use Category: Research Use Only
This batch is linked to analytical documentation intended to support traceability and laboratory recordkeeping.
The COA may include:
• batch identification
• analytical purity results
• identity verification
• method reference information
This page applies only to the lot number listed above.
Documentation shown here is batch-specific and should not be used as a reference for other lots or product versions.
This material is supplied strictly for laboratory research purposes.
It is not intended for:
• human use
• veterinary use
• diagnostic applications
• therapeutic or clinical applications
True Peptides does not provide dosing guidance, administration instructions, or usage recommendations.
All analytical data provided is batch-specific and linked to the corresponding product.
Transparency in documentation allows for:
True Peptides prioritizes accessible and verifiable documentation as a core part of its quality framework.
Peptide materials are supplied as lyophilized powders.
Recommended storage: 2–8°C refrigerated, unless otherwise specified.
Proper storage conditions are required to maintain material integrity. Stability may vary depending on peptide structure and environmental exposure.
Handling should be performed within controlled laboratory conditions.
